Company Filing History:
Years Active: 2003
Title: Mary Ann Hoermann: Innovator in Anti-Inflammatory Research
Introduction
Mary Ann Hoermann is a distinguished inventor based in Holmes, NY, recognized for his significant contributions to the field of pharmaceuticals. His innovative work has led to the development of a patent focused on anti-inflammatory agents, demonstrating his commitment to advancing medical science.
Latest Patents
Mary Ann Hoermann holds a patent for "Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents." This patent describes the compounds of 1-(4-aminophenyl)pyrazoles, which are selectively substituted on the 3- and 5-positions of the pyrazole ring and on the amino group at the 4-position of the phenyl ring. Notably, these pyrazoles have been shown to inhibit IL-2 production in T-lymphocytes, highlighting their potential effectiveness in treating inflammatory conditions.
Career Highlights
Throughout his career, Mary Ann has demonstrated exceptional innovation while working at Boehringer Ingelheim Pharmaceuticals, Inc. His dedication and expertise in pharmaceutical research have not only contributed to the development of new therapeutic agents but also placed him at the forefront of anti-inflammatory research within the industry.
Collaborations
Mary Ann Hoermann has worked alongside notable coworkers, including Rajashekhar Betageri and Charles Lawrence Cywin. Their collaborative efforts have fostered an environment conducive to innovation, leading to advancements in the field of pharmaceuticals, particularly in the development of novel anti-inflammatory agents.
Conclusion
Mary Ann Hoermann is a pivotal figure in pharmaceutical innovation, particularly recognized for his contributions to anti-inflammatory research. His patent on substituted pyrazoles exemplifies the potential of innovative science to address pressing medical needs and improve patients' lives. As he continues to work at Boehringer Ingelheim Pharmaceuticals, Inc., his future endeavors are anticipated to yield further advancements in medical treatment options.